|
|
 |
|
|
|
|
|
|
What we are looking for
Virology: A Top Company in HIV/AIDS treatment.
A constant pursuit of new treatments.
Our commitment to the HIV/AIDS community is a driving force in our discovery and development programs, and in our success. We are constantly reminded of our corporate mission to extend and enhance human life. In addition to HIV/AIDS treatments, we are also seeking treatments for hepatitis.
Doing the right things in HIV/AIDS treatment.
Our current products for HIV/AIDS are cornerstones in treatment. In fact, through our five-year, $115 million "SECURE THE FUTURE" initiative, we are providing support for women and children infected or affected by HIV/AIDS in nine countries in southern and West Africa, where the AIDS crisis is most accute.
Continuing innovation in infectious disease treatment.
Six decades ago, discoveries by Bristol-Myers Squibb helped make the mass production of penicillin possible. Today, we are still the largest manufacturer of penicillin in the world, and the maker of some of the world's most prescribed antibiotics, including Cefzil® (cefprozil) tablets, and Tequin® (gatifloxacin) tablets. Further, our commitment to infectious disease has led us to fund SENTRY, the world's first global surveillance program to monitor bacterial resistance.
|
[Top Page] [Search]
[Index] [Contact] [Home]
Italicized product names are trademarks of Bristol-Myers Squibb Company or one of its divisions or subsidiaries. Abilify is a trademark of Otsuka Pharmaceutical Co., Ltd. Atripla is a trademark of Bristol-Myers Squibb & Gilead Sciences, LLC.
Erbitux is a trademark of ImClone Systems Incorporated. EMSAM is a trademark of Somerset Pharmaceuticals, Inc. Glucophage, Glucovance and Metaglip are trademarks of Merck Santé S.A.S., an associate of Merck KGaA of Darmstadt, Germany. Avapro, Avalide and Plavix are trademarks of sanofi-aventis. Sinemet CR is a trademark of Merck & Co., Inc.
© 1999-2008 Bristol-Myers Squibb Company. Your use of the information on this site is subject to the terms of our Legal Notice and Privacy Policy. |
|
|
